Search results (79)
« Back to PublicationsBCG enables protection against malaria through adjuvanting an adenovirus-vectored vaccine.
Journal article
Reinke S. et al, (2026), NPJ vaccines
Protocol for precision cutting and short-term culture of lymph node tissue slices for modeling of innate immune responses ex vivo.
Journal article
Fergusson JR. et al, (2026), STAR protocols, 7
Early lymph node T follicular helper cell signalling hub drives influenza vaccine response in an ancestrally diverse cohort
Journal article
Siu JHY. et al, (2025), eBioMedicine, 122, 106036 - 106036
Ex vivo model of functioning human lymph node reveals role for innate lymphocytes and stroma in response to vaccine adjuvant
Journal article
Fergusson JR. et al, (2025), Cell Reports, 44, 115938 - 115938
Core-shell microcapsules compatible with routine injection enable prime/boost immunization against malaria with a single shot
Journal article
Guyon R. et al, (2025), Science Translational Medicine, 17
Injectable core-shell microcapsules deliver prime-boost immunisation against malaria in a single shot
Preprint
Guyon R. et al, (2024)
Emulsion and liposome-based adjuvanted R21 vaccine formulations mediate protection against malaria through distinct immune mechanisms
Journal article
Reinke S. et al, (2023), Cell Reports Medicine, 4, 101245 - 101245
Injectable core-shell microspheres deliver prime-boost immunisation in a single shot
Preprint
Guyon R. et al, (2023)
The role and uses of antibodies in COVID-19 infections: a living review
Journal article
Scourfield DO. et al, (2021), Oxford Open Immunology, 2
Mucosal immune responses in COVID19 - a living review
Journal article
Pearson CF. et al, (2021), Oxford Open Immunology, 2
T cell phenotypes in COVID-19 - a living review
Journal article
Hanna SJ. et al, (2021), Oxford Open Immunology, 2
Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology
Journal article
Codd AS. et al, (2021), Oxford Open Immunology, 2
TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases.
Journal article
Luchner M. et al, (2021), Pharmaceutics, 13